EN DE
STOCK COMPARISON

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A as the less overvalued of the two: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A trades at ¥22.06 versus a fair value of ¥19.93 (-10%), while Jiangsu Hengrui Medicine Co trades at ¥54.18 versus ¥25.94 (-52%).
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
002864.SHE · CNY · Health Care
-10%
upside to fair value
fairly valued
Price¥22.06
Fair Value¥19.93
Quality46/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-52%
upside to fair value
overvalued
Price¥54.18
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class AJiangsu Hengrui Medicine Co
Valuation
33.2×P/E (TTM)43.6×
2.63×P/S (TTM)10.84×
1.74×P/B5.76×
15.6×EV/EBITDA33.0×
—PEG0.93×
1.3%Dividend yield0.4%
¥0.35Dividend per share¥0.20
Profitability
8%Net margin25%
13%Operating margin32%
5%Return on equity15%
2%Return on assets9%
Growth
-11%Revenue growth (YoY)13%
5.4%Avg. growth/yr (3Y)13.9%
11.2%Avg. growth/yr (5Y)2.5%
Balance & size
0.06×Debt / equity—
$435MMarket cap$52B
expensiveGrowth qualityhealthy

Even match: 6 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class Aof which business quality 48 · market factors 25 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 47
ProfitabilityMargins and returns on capital today
38
63
Quality GrowthAre margins and returns improving?
45
41
CashflowEarnings quality: real cash, not paper profit
16
82
Fin. StrengthBalance sheet, leverage, solvency risk
99
100
InvestmentDisciplined investing over empire-building
53
27
Low VolatilityCalm price path (market factor)
64
78
MomentumPrice trend over the last 3–12 months (market factor)
13
37
52W MomentumDistance to the 52-week high (market factor)
4
29
Net IssuanceBuybacks instead of dilution
35
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

DCF Models¥25.20
Earnings-Based¥15.50
Dividend Discount¥6.74
Multiples¥22.13
Asset-Based¥10.63
Growth DCF¥18.90
Economic Profit¥17.69
Growth Earnings¥18.00

14 of 26 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
Bear ¥14.95Fair Value ¥19.93Bull ¥24.91
¥22.06 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥54.18 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A · Health Care

Quality score46 · below median
Fair value upside-10% · above median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-52% · below median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A as the less overvalued of the two: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A trades at ¥22.06 versus a fair value of ¥19.93 (-10%), while Jiangsu Hengrui Medicine Co trades at ¥54.18 versus ¥25.94 (-52%).

Jiangsu Hengrui Medicine Co has the higher quality score (66/100).

See the full analysis →
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A · Jiangsu Hengrui Medicine Co

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Jiangsu Hengrui Medicine Co

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.